美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

信息服務

4.12

-0.1400-3.29%

盤後：4.120.00000.00%19:34 EDT

成交量：16.93萬

成交額：69.72萬

市值：1.97億

市盈率：19.62

高：4.26

開：4.26

低：4.06

收：4.26

52周最高：6.45

52周最低：3.74

股本：4,788.41萬

流通股本：3,498.93萬

量比：0.88

換手率：0.48%

股息：0.18

股息率：4.37%

每股收益(TTM):0.2100

每股收益(LYR):0.1900

淨資產收益率：11.17%

總資產收益率：5.99%

市淨率：2.09

市盈率(LYR):21.68

資料載入中...

總覽公司新聞公告

遠大醫藥(00512)核藥戰略伙伴Telix全球首創rADC國際多中心III期獲積極進展，前列腺癌治療添新希望！

軒竹生物-B(02575)漲逾8% 安久衞治療反流性食管炎III期試驗完成全部受試者入組

康寧傑瑞製藥-B(09966)：KN026輔助治療HER2+乳腺癌III期臨床研究完成首例患者給藥

華萊士成立信息服務公司，註冊資本5000萬

经济观察网

和黃醫藥(00013)啓動HMPL-760用於治療復發/難治性瀰漫性大B細胞淋巴瘤的中國III期臨床試驗

宜明昂科-B(01541)成功完成IMM01(替達派西普)用於慢性粒-單核細胞白血病(CMML)一線治療的III期臨床試驗中期分析的133例患者招募

四環醫藥附屬創新藥III期臨床試驗完成500名受試者入組

軒竹生物-B(02575)：安奈拉唑鈉腸溶片(安久衞®)治療反流性食管炎中國III期臨床試驗完成全部受試者入組

迪哲醫藥(688192.SH)：舒沃哲®單藥一線治療EGFRexon20ins非小細胞肺癌國際多中心III期臨床試驗獲陽性頂線結果

康寧傑瑞製藥-B(09966.HK)：JSKN016用於治療TNBC的III期臨床研究完成首例患者給藥

吉利德科學(GILD.US)CD19/CD20 CAR-T細胞療法啓動III期臨床

開拓藥業-B(09939)：KX-826酊1.0%治療中國成年男性雄激素脱髮關鍵性臨床試驗III期階段達到主要終點

華海藥業(600521.SH)：HB0025注射液啓動子宮內膜癌III期臨床試驗

美國懸賞千萬美元徵集伊朗高層官員情報

聯儲局將啓動為期 90 天的巴塞爾協議 III 提案徵詢期，比特幣面臨 1250% 風險權重

中國生物製藥：IDH1抑制劑TQB3454膽道癌III期臨床達優效終點

南方财经网

港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》

智通财经网

和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果

信息服務集團發布2026年第一季度業績指引：營收預計6050萬至6150萬美元，調整後EBITDA達750萬至850萬美元

阿斯利康重磅炸彈在國內啓動新 III 期臨床

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/III/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服務","latestPrice":4.12,"timestamp":1785441600000,"preClose":4.26,"halted":0,"volume":169334,"hourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"19:34 EDT","volume":3223,"amount":13278.76,"timestamp":1785454449327,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03286384976525814,"floatShares":34989300,"shares":47884104,"eps":0.209971,"marketStatus":"未開盤","change":-0.14,"latestTime":"07-30 16:00:00 EDT","open":4.255,"high":4.255,"low":4.06,"amount":697249.593733,"amplitude":0.045775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.209971,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1785484800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.26,"dividendRate":0.043689,"preHourTrading":{"tag":"盘前","latestPrice":4.19,"preClose":4.26,"latestTime":"09:29 EDT","volume":136,"amount":574.3400088,"timestamp":1785418141106,"change":-0.07,"changeRate":-0.016432,"amplitude":0.049296},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"19:34 EDT","volume":3223,"amount":13278.76,"timestamp":1785454449327,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.87989,"impliedVol":1.7448,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34989300,"roa":"5.99%","roe":"11.17%","lyrEps":0.19,"volumeRatio":0.87989,"shares":47884104,"dividePrice":0.18,"high":4.255,"amplitude":0.045775,"preClose":4.26,"low":4.06,"week52Low":3.74,"pbRate":"2.09","psRate":"0.80","week52High":6.4495,"institutionHeld":0.6684,"latestPrice":4.12,"eps":0.209971,"divideRate":0.043689,"volume":169334,"delay":0,"ttmEps":0.209971,"open":4.255,"prevYearClose":5.78,"prevWeekClose":3.86,"prevMonthClose":4.11,"prevQuarterClose":4.11,"fiveDayClose":3.84,"twentyDayClose":4.19,"sixtyDayClose":4.12,"earningDate":1785859200000,"earningTime":"盘后","dividendPayoutRate":0.9280598907982862,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.03333720106347336},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2026-08-05","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0.06,"defaultRemindTime":1785960000000,"name":null,"time":"盤後","dateTimestamp":1785902400000,"actualEps":null},{"date":"2026-06-05","symbol":"III","amount":0.045,"announcedDate":"2026-05-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-05","defaultRemindTime":1780666200000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-05","currency":"USD","dateTimestamp":1780632000000,"payDate":"2026-06-26"},{"market":"US","date":"2026-05-07","symbol":"III","fiscalQuarterEnding":"2026/03","expectedEps":0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0.06},{"date":"2026-03-20","symbol":"III","amount":0.045,"announcedDate":"2026-03-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-26"},{"market":"US","date":"2026-03-05","symbol":"III","fiscalQuarterEnding":"2025/12","expectedEps":0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2026-07-29","current":19.621757,"percent":0.521987,"low":-221.876594,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"high":68.328883,"avg":1.104082,"sd":58.997004,"marketCap":198532987},"quantilePoints":[{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-16","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025},{"date":"2025-05-23","current":29.29984,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":226077566},{"date":"2025-05-30","current":29.237367,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":225595524},{"date":"2025-06-06","current":29.424786,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":227041650},{"date":"2025-06-13","current":29.862097,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":230415942},{"date":"2025-06-20","current":29.612205,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":228487775},{"date":"2025-06-27","current":28.862529,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":222703274},{"date":"2025-07-03","current":31.923706,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":246323318},{"date":"2025-07-11","current":31.486395,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":242949026},{"date":"2025-07-18","current":29.237367,"twenty":12.58915,"median":18.866214,"eighty":34.89521,"marketCap":225595524},{"date":"2025-07-25","current":28.425218,"twenty":12.58915,"median":18.866214,"eighty":34.834126,"marketCap":219328982},{"date":"2025-08-01","current":26.925866,"twenty":12.58915,"median":18.866214,"eighty":34.784891,"marketCap":207759981},{"date":"2025-08-08","current":25.754678,"twenty":12.58915,"median":18.866214,"eighty":34.77297,"marketCap":202457522},{"date":"2025-08-15","current":30.470866,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":239531480},{"date":"2025-08-22","current":29.489913,"twenty":12.58915,"median":18.866214,"eighty":34.221243,"marketCap":231820205},{"date":"2025-08-29","current":31.39051,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":246760801},{"date":"2025-09-05","current":32.432773,"twenty":12.58915,"median":18.85295,"eighty":34.118522,"marketCap":254954031},{"date":"2025-09-12","current":32.126225,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":252544257},{"date":"2025-09-19","current":33.965513,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":267002898},{"date":"2025-09-26","current":35.314324,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":277605901},{"date":"2025-10-03","current":34.639918,"twenty":12.58915,"median":18.866214,"eighty":34.639918,"marketCap":272304399},{"date":"2025-10-10","current":33.842894,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":266038988},{"date":"2025-10-17","current":33.413727,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":262665306},{"date":"2025-10-24","current":34.088132,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":267966807},{"date":"2025-10-31","current":33.536346,"twenty":12.58915,"median":18.866214,"eighty":34.748399,"marketCap":263629215},{"date":"2025-11-07","current":28.380485,"twenty":12.58915,"median":18.866214,"eighty":34.701228,"marketCap":277248962},{"date":"2025-11-14","current":25.733601,"twenty":12.58915,"median":18.866214,"eighty":34.517299,"marketCap":251391546},{"date":"2025-11-21","current":24.557208,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":239899361},{"date":"2025-11-28","current":26.370814,"twenty":12.58915,"median":18.866214,"eighty":34.210751,"marketCap":257616479},{"date":"2025-12-05","current":28.282453,"twenty":12.58915,"median":18.866214,"eighty":33.965513,"marketCap":276291280},{"date":"2025-12-12","current":29.409829,"twenty":12.58915,"median":18.866214,"eighty":33.842894,"marketCap":287304624},{"date":"2025-12-19","current":29.26278,"twenty":12.58915,"median":18.866214,"eighty":33.529773,"marketCap":285868100},{"date":"2025-12-26","current":29.066715,"twenty":12.58915,"median":18.866214,"eighty":33.430508,"marketCap":283952736},{"date":"2026-01-02","current":28.331469,"twenty":12.58915,"median":18.866214,"eighty":33.342648,"marketCap":276770121},{"date":"2026-01-09","current":29.164747,"twenty":12.58915,"median":18.866214,"eighty":33.210859,"marketCap":284910418},{"date":"2026-01-16","current":29.80196,"twenty":12.58915,"median":18.866214,"eighty":33.054432,"marketCap":291135352},{"date":"2026-01-23","current":27.792289,"twenty":12.58915,"median":18.866214,"eighty":32.903351,"marketCap":271502869},{"date":"2026-01-30","current":27.400158,"twenty":12.58915,"median":18.866214,"eighty":32.739321,"marketCap":267672141},{"date":"2026-02-06","current":24.998355,"twenty":12.58915,"median":18.866214,"eighty":32.548436,"marketCap":244208930},{"date":"2026-02-13","current":22.35147,"twenty":12.58915,"median":18.866214,"eighty":32.359621,"marketCap":218351514},{"date":"2026-02-20","current":22.841634,"twenty":12.58915,"median":18.866214,"eighty":32.126225,"marketCap":223139924},{"date":"2026-02-27","current":23.429831,"twenty":12.58915,"median":18.866214,"eighty":32.068687,"marketCap":228886017},{"date":"2026-03-06","current":24.400849,"twenty":12.58915,"median":18.866214,"eighty":31.936898,"marketCap":227928335},{"date":"2026-03-13","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.809821,"marketCap":191174107},{"date":"2026-03-20","current":19.649525,"twenty":12.58915,"median":18.866214,"eighty":31.731279,"marketCap":183546212},{"date":"2026-03-27","current":19.7516,"twenty":12.58915,"median":18.866214,"eighty":31.635749,"marketCap":184499699},{"date":"2026-04-02","current":19.598487,"twenty":12.58915,"median":18.866214,"eighty":31.486395,"marketCap":183069469},{"date":"2026-04-10","current":20.415091,"twenty":12.58915,"median":18.866214,"eighty":31.417108,"marketCap":190697364},{"date":"2026-04-17","current":21.282732,"twenty":12.58915,"median":18.866214,"eighty":31.338565,"marketCap":198802001},{"date":"2026-04-24","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.102233,"marketCap":191174107},{"date":"2026-05-01","current":20.823393,"twenty":12.58915,"median":18.866214,"eighty":30.970444,"marketCap":194511311},{"date":"2026-05-08","current":18.809916,"twenty":12.58915,"median":18.839687,"eighty":30.838724,"marketCap":198802001},{"date":"2026-05-15","current":19.2371,"twenty":12.58915,"median":18.809916,"eighty":30.611773,"marketCap":203316914},{"date":"2026-05-22","current":19.780266,"twenty":12.58915,"median":18.739199,"eighty":30.409557,"marketCap":209057627},{"date":"2026-05-29","current":20.504486,"twenty":12.58915,"median":18.718829,"eighty":30.267569,"marketCap":216711911},{"date":"2026-06-05","current":19.644474,"twenty":12.58915,"median":18.739199,"eighty":30.174462,"marketCap":207622449},{"date":"2026-06-12","current":19.372892,"twenty":12.58915,"median":18.739199,"eighty":30.111989,"marketCap":204752092},{"date":"2026-06-18","current":18.829726,"twenty":12.58915,"median":18.698459,"eighty":29.987245,"marketCap":199011379},{"date":"2026-06-26","current":18.377089,"twenty":12.58915,"median":18.492688,"eighty":29.953208,"marketCap":194227452},{"date":"2026-07-02","current":18.965518,"twenty":12.58915,"median":18.492688,"eighty":29.862097,"marketCap":200446558},{"date":"2026-07-10","current":18.422353,"twenty":12.58915,"median":18.42051,"eighty":29.749013,"marketCap":194705845},{"date":"2026-07-17","current":18.558144,"twenty":12.58915,"median":18.377089,"eighty":29.67784,"marketCap":196141023},{"date":"2026-07-24","current":17.381286,"twenty":12.58915,"median":18.28067,"eighty":29.612205,"marketCap":183702812},{"date":"2026-07-29","current":18.784463,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"marketCap":198532987}],"updateTime":1785451390153},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621406605","title":"遠大醫藥(00512)核藥戰略伙伴Telix全球首創rADC國際多中心III期獲積極進展，前列腺癌治療添新希望！","url":"https://stock-news.laohu8.com/highlight/detail?id=2621406605","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621406605?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 18:59","pubTimestamp":1774349976,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，远大医药核药领域战略合作伙伴澳洲Telix公司传来重磅利好，其用于治疗前列腺癌的全球首创的镥标记的治疗性放射性抗体药物偶联物候选药物TLX591-Tx国际多中心III期临床试验的第一部分已成功达到主要目标，证明了该产品的安全性和耐受性，且未观察到新的不良反应，不仅促进了该创新产品未来的进一步开发及上市，同时也体现了前列腺癌治疗未来有望获得全新选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000876","BK0012","BK0028","00512","BK4134","BK0238","BK0187","III","BK1191","BK0183","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621603174","title":"軒竹生物-B(02575)漲逾8% 安久衞治療反流性食管炎III期試驗完成全部受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2621603174","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621603174?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 10:10","pubTimestamp":1774318245,"startTime":"0","endTime":"0","summary":"消息面上，四环医药发布公告，公司旗下非全资附属公司轩竹生物科技股份有限公司的创新药安奈拉唑钠肠溶片用于治疗成人反流性食管炎的中国III期临床试验已顺利完成全部500名受试者入组。据悉，安奈拉唑钠肠溶片于2023年6月获得中国国家药品监督管理局批准上市，用于患者治疗十二指肠溃疡。此次III期临床研究于2025年7月全面展开，近期完成受试者入组，标志着本公司在创新药物研发方面取得了重要进展。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977089","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4134","III","BK1593","00460","BK1600","02575","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621337490","title":"康寧傑瑞製藥-B(09966)：KN026輔助治療HER2+乳腺癌III期臨床研究完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2621337490","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621337490?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 08:07","pubTimestamp":1774310843,"startTime":"0","endTime":"0","summary":"双靶向联合化疗辅助治疗HER2+ BC 对比仅含曲妥珠单抗的方案，可进一步降低复发风险，其中淋巴结阳性人群的获益最为显著。KN026-007是一项随机、对照、开放、多中心III期临床研究，预计纳入约1,800例术后组织学确认区域淋巴结阳性数量≥4个的可切除HER2+ BC患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK1574","BK4134","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621672560","title":"華萊士成立信息服務公司，註冊資本5000萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2621672560","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621672560?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 10:40","pubTimestamp":1774233600,"startTime":"0","endTime":"0","summary":"经济观察网 天眼查工商信息显示，近日，福州华莱士信息有限公司成立，法定代表人为华鹏程，注册资本5000万人民币，经营范围为社会经济咨询服务、企业管理咨询、企业管理、供应链管理服务。股东信息显示，该公司由福建省华莱士食品股份有限公司全资持股。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-03-23/doc-inhrxvtz4211545.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-23/doc-inhrxvtz4211545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621747577","title":"和黃醫藥(00013)啓動HMPL-760用於治療復發/難治性瀰漫性大B細胞淋巴瘤的中國III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747577","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621747577?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 08:08","pubTimestamp":1774224537,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，本公司今日宣布在中国启动HMPL-760联合R-GemOx 方案用于治疗复发/难治性弥漫性大 B细胞淋巴瘤患者的注册性III期临床试验。该研究是一项随机、双盲、阳性对照的III期临床研究，旨在评估HMPL-760联合R-GemOx方案对比安慰剂联合RGemOx方案用于治疗既往接受过一线系统化疗、免疫治疗或免疫化疗联合治疗后复发或难治性且不适合移植的弥漫性大B细胞淋巴瘤患者的疗效、安全性和药代动力学。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1191","BK4134","00013","BK4007","III","HCM","BK1587","BK4531","BK1588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621742594","title":"宜明昂科-B(01541)成功完成IMM01(替達派西普)用於慢性粒-單核細胞白血病(CMML)一線治療的III期臨床試驗中期分析的133例患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=2621742594","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621742594?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 07:22","pubTimestamp":1774221759,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，本公司成功完成IMM01用于慢性粒-单核细胞白血病一线治疗的III期临床试验中期分析的133例患者招募。此外，IMM01的CD47结合结构域经过特别改造能够避免与人体红细胞结合。凭藉差异化的分子设计，IMM01表现出良好的安全性并证实其激活巨噬细胞的能力。IMM01联合阿扎胞苷进行CMML一线治疗于2023年11月获美国食品药品监督管理局授予的孤儿药资格认定。本集团拥有IMM01的全球知识产权及商业化权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK4134","01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621124714","title":"四環醫藥附屬創新藥III期臨床試驗完成500名受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2621124714","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621124714?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 18:34","pubTimestamp":1774175640,"startTime":"0","endTime":"0","summary":"3月22日，四环医药（00460）发布公告，本公司旗下非全资附属公司轩竹生物科技股份有限公司的创新药安奈拉唑钠肠溶片（商品名：安久卫?）用于治疗成人反流性食管炎的中国III期临床试验已顺利完成全部500名受试者入组。该试验是一项多中心、随机、双盲双模拟、阳性药物平行对照的关键性研究，旨在评估安奈拉唑钠肠溶片治疗中国成年反流性食管炎受试者的有效性和安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603223679754978.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679754978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00460","BK1191","BK1515","BK4134","159992","BK1593","BK1161","BK1574","BK1600","06978","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621714992","title":"軒竹生物-B(02575)：安奈拉唑鈉腸溶片(安久衞®)治療反流性食管炎中國III期臨床試驗完成全部受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714992?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 18:33","pubTimestamp":1774175605,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B 发布公告，公司自主研发的创新药安奈拉唑钠肠溶片用于治疗成人反流性食管炎的中国III期临床试验已于近日顺利完成全部500名受试者入组。该项III期临床试验是一项多中心、随机、双盲双模拟、阳性药物平行对照的关键性研究，旨在评估安奈拉唑钠肠溶片治疗中国成年反流性食管炎受试者的有效性和安全性。安全性指标主要为不良事件的发生类型、发生率、严重程度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","02575","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621719302","title":"迪哲醫藥(688192.SH)：舒沃哲®單藥一線治療EGFRexon20ins非小細胞肺癌國際多中心III期臨床試驗獲陽性頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2621719302","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621719302?lang=zh_tw&edition=fundamental","pubTime":"2026-03-22 15:43","pubTimestamp":1774165425,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪哲医药(688192.SH)公告，公司自主研发的产品舒沃哲®(ZEGFROVY®，通用名：舒沃替尼片)单药一线治疗表皮生长因子受体(EGFR)20号外显子插入突变(exon20ins)晚期非小细胞肺癌(NSCLC)的国际多中心III期临床研究“悟空28”(WU-KONG28)达到主要研究终点、取得阳性顶线结果，是全球首个且唯一在国际多中心随机对照III期临床研究中，针对EGFRexon20ins NSCLC一线治疗取得阳性结果的口服靶向药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK0239","688192","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620270254","title":"康寧傑瑞製藥-B(09966.HK)：JSKN016用於治療TNBC的III期臨床研究完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2620270254","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620270254?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 08:17","pubTimestamp":1773965823,"startTime":"0","endTime":"0","summary":"格隆汇3月20日丨康宁杰瑞制药-B发布公告，JSKN016用于治疗三阴性乳腺癌的一项III期临床研究已成功完成首例患者给药。TNBC约占所有BC病例的15%至20%。　　JSKN016-301是一项开放、随机、对照、多中心III期临床研究，预计将在中国约60家临床研究中心开展。该研究计划入组经至少二线系统性治疗失败的不可手术切除的局部晚期、复发或转移性TNBC患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260320/32083524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["III","BK1574","BK4134","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620225813","title":"吉利德科學(GILD.US)CD19/CD20 CAR-T細胞療法啓動III期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225813?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 21:12","pubTimestamp":1773925932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月18日，美国临床试验收录网站显示，吉利德科学旗下公司Kite Pharma启动了KITE-753的首个III期临床试验。KITE-753是一款靶向CD19和CD20的双顺反子自体CAR-T细胞疗法。研究的主要终点是第6个月实现完全缓解的患者比例和36个月内的无事件生存期。结果显示，剂量3队列，在14例未接受过CAR-T细胞疗法治疗的患者中，11例实现CR，CR率为79%;总人群，在20例未接受过CAR-T细胞疗法治疗的患者中，14例实现CR，CR率为70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999015945.SGD","IE00BKVL7J92.USD","III","LU0122379950.USD","LU0823416689.USD","LU0882574055.USD","LU0058720904.USD","LU0289739699.SGD","LU2112291526.USD","LU1037948897.HKD","LU1571399168.USD","LU1934455863.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU1023059063.AUD","LU0965508806.USD","LU0114720955.EUR","LU0965509010.AUD","LU0965509283.SGD","LU1066051498.USD","LU1585245621.USD","SG9999015952.SGD","BK4583","LU0234570918.USD","LU1839511570.USD","SG9999015986.USD","LU0109394709.USD","LU1061106388.HKD","LU1037948541.HKD","LU0965509101.SGD","BK4022","LU1430594728.SGD","BK4134","LU0861579265.USD","BK4588","LU2089984988.USD","BK4139","BK4532","IE00B19Z3581.USD","LU1674673428.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","BK4568","LU0889565916.HKD","LU2087621335.USD","IE00B3T34201.USD","SG9999015978.USD","CAR","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620256274","title":"開拓藥業-B(09939)：KX-826酊1.0%治療中國成年男性雄激素脱髮關鍵性臨床試驗III期階段達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2620256274","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620256274?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 20:59","pubTimestamp":1773838785,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开拓药业-B 发布公告，其自主研发、潜在同类首创的 KX-826酊1.0%治疗脱发的关键性临床试验III期阶段已获得顶线数据。KX-826作为公司目前进展最快的外用创新药物之一，自开发以来已在中国和美国完成针对男性及女性的多项用于治疗脱发的临床试验，并表现出优异的有效性及安全性。该药物和KX-826均有望作为一种治疗雄激素性脱发的全新疗法，为广大脱发患者提供了更安全且有效的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","09939","BK4134","BK1515","III"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620234995","title":"華海藥業(600521.SH)：HB0025注射液啓動子宮內膜癌III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2620234995","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620234995?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 18:11","pubTimestamp":1773828691,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华海药业(600521.SH)公告，公司下属子公司上海华奥泰生物药业股份有限公司(“华奥泰”)就HB0025联合化疗一线治疗晚期/复发子宫内膜癌经过与国家药品监督管理局药品审评中心(“CDE”)Ⅱ期临床试验结束/Ⅲ期临床试验启动前的会议沟通，公司将正式启动HB0025注射液子宫内膜癌的Ⅲ期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK0239","BK0070","600521","BK0028","BK4134","BK0201","BK0012","III","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125277344","title":"美國懸賞千萬美元徵集伊朗高層官員情報","url":"https://stock-news.laohu8.com/highlight/detail?id=1125277344","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125277344?lang=zh_tw&edition=fundamental","pubTime":"2026-03-14 04:08","pubTimestamp":1773432503,"startTime":"0","endTime":"0","summary":"美国当局宣布，将提供最高1000万美元的悬赏金，征集被其指认为伊朗伊斯兰革命卫队核心领导层人员的情报。这份公告明确列出了六名人员的姓名，其中包括伊朗新任最高领袖穆杰塔巴·哈梅内伊及高级国家安全官员阿里·拉里贾尼。\n公告未具体说明获得赏金所需提供的信息类型。该消息属于实时新闻报道环节的一部分，完整内容可通过特定渠道获取。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619159552","title":"聯儲局將啓動為期 90 天的巴塞爾協議 III 提案徵詢期，比特幣面臨 1250% 風險權重","url":"https://stock-news.laohu8.com/highlight/detail?id=2619159552","media":"链捕手","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619159552?lang=zh_tw&edition=fundamental","pubTime":"2026-03-13 11:02","pubTimestamp":1773370922,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据市场消息，美联储负责监管事务的副主席米歇尔·鲍曼表示，美国监管机构将在未来几周内提出实施巴塞尔协议 III 最终阶段的规则提案，预计于 3 月 17 日至 21 日这一周发布，随后将开放 90 天的公众意见征询期。\n\n该提案由美联储与货币监理署和联邦存款保险公司协调制定。根据巴塞尔委员会 2022 年最终确定的全球加密框架，比特币被归入监管机构认为难以对冲且固有波动性的第 2b 组资产，面临 1250% 的风险权重。这意味着银行持有 1 亿美元比特币敞口，将被视为 12.5 亿美元风险加权资产，需为此持有约 1 亿美元资本。\n\n与现金、黄金和美国国债的零风险权重以及企业贷款 20%-100% 的范围相比，比特币的资本处理极为严苛。加密行业机构批评该框架将比特币错误分类，阻止银行提供相关服务。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2251615","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US12M.BOND","SBIT","FAZ","ESmain","US7Y.BOND","BND","BTCI","BITB","03439","BTCO","MBTmain","GBTC",".SPX","US30Y.BOND","BTC","BTC.USD.CC","03042","SHV","BTC.USD.HKCC","US6M.BOND","BOXX","BITU","IEI","III","ARKB","BIL","FBTC","HK0000934320.USD","09042","SKRE","US10Y.BOND","US5Y.BOND","TMF","ZBmain","09008","VOO","TLTW","BITX","HYG","US2Y.BOND","03008","IEF","BITI","SPY","US3Y.BOND","09439","SHY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618827251","title":"中國生物製藥：IDH1抑制劑TQB3454膽道癌III期臨床達優效終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2618827251","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618827251?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 17:09","pubTimestamp":1773306598,"startTime":"0","endTime":"0","summary":"中国生物制药：IDH1抑制剂TQB3454胆道癌III期临床达优效终点","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603123670208055.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603123670208055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["III","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","01177","BK1521","BK4134","BK1515","HK0000165453.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618985985","title":"港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》","url":"https://stock-news.laohu8.com/highlight/detail?id=2618985985","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618985985?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 13:36","pubTimestamp":1773121010,"startTime":"0","endTime":"0","summary":"和誉-B(02256)再涨超9%，截至发稿，涨8.76%，报12.91港元，成交额2199.69万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2778985437.USD","BK4134","LU2488822045.USD","BK4585","BK1161","LU2476274720.SGD","BK4588","VXUS","IE00BPRC5H50.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","02256","LU2476274308.USD","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618692617","title":"和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692617","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618692617?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 08:03","pubTimestamp":1773014618,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布，其自主研发的新型、口服、高选择性且高效的小分子CSF-1R抑制剂贝捷迈®(盐酸匹米替尼胶囊，ABSK021)的全球多中心III期MANEUVER研究结果，于3月5日(西欧时间)正式发表于国际医学期刊《柳叶刀》 (The Lancet)1。此次发表标志着和誉医药这一创新疗法在临床研究质量、数据完整性及国际学术认可度方面取得了重要里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2476274308.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2778985437.USD","BK4134","02256","LU2476274720.SGD","LU2488822045.USD","III","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125385117","title":"信息服務集團發布2026年第一季度業績指引：營收預計6050萬至6150萬美元，調整後EBITDA達750萬至850萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125385117","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125385117?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 05:30","pubTimestamp":1772746217,"startTime":"0","endTime":"0","summary":"信息服务集团（Information Services Group）近日公布了2026年第一季度的财务预期。根据公司指引，当期营收预计将落在6050万至6150万美元区间，调整后的税息折旧及摊销前利润（EBITDA）预计为750万至850万美元。\n这一业绩指引反映出公司对核心业务持续增长的信心。通过优化运营效率和深化客户合作，信息服务集团正稳步推进其战略目标。市场将密切关注该公司后续的财务表现，以评估其长期发展潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617577516","title":"阿斯利康重磅炸彈在國內啓動新 III 期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2617577516","media":"求实药社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617577516?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 12:03","pubTimestamp":1772683402,"startTime":"0","endTime":"0","summary":"来源：丁香园Insight数据库3 月 4 日，药物临床试验登记与信息公示平台官网显示，阿斯利康登记了一项特泽利尤单抗用于鼻内镜下鼻息肉评分 ≥4 分慢性鼻窦炎伴鼻息肉成人患者附加维持治疗的 IIIb 期临床研究。用药方案为每 4 周皮下注射一次，合计 24 周。通过精准阻断 TSLP，特泽利尤单抗可从源头抑制相关炎症通路激活，从而缓解疾病症状。目前，特泽利尤单抗已经在美国、日本、欧盟获批 2 项适应症，分别是哮喘、慢性鼻窦炎伴鼻息肉病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030514022597a82446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030514022597a82446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","III","BK4134","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","IE00B3T34201.USD","LU0320765992.SGD","LU2456880835.USD","LU2462157665.USD","LU0058720904.USD","LU1829250122.USD","LU0289739699.SGD","LU2236285917.USD","BK4007","BK4568","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":167,"code":"91000000","status":"200"}]}}